Validation and Feasibility of Noninvasive Oxygen Delivery Index Monitoring in Cardiac Surgery Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Minnesota

About this trial

This study will establish the feasibility and preliminary validity of real-time oxygen delivery index (DO₂i) monitoring using noninvasive hemoglobin (SpHb, Masimo) and minimally invasive cardiac output (FloTrac, Edwards) in cardiac surgery patients.

Eligibility criteria

Qualifiers

Adults ≥ 18 years undergoing cardiac surgery

Placement of pulmonary artery catheter with continuous cardiac output (CCO) as part of routine clinical care

Placement of arterial line with FloTrac as part of routine clinical care

Availability of ≥ 3 arterial blood gas samples at specified timepoints

Disqualifiers

Mechanical circulatory support planned or in use (IABP, Impella, ECMO)

Patients without BOTH pulmonary artery catheter with CCO and arterial line with FloTrac

Patients who are Research Opt-Out

Trial design

Treatments tested in this trial

  • SpHb monitor

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators